• Je něco špatně v tomto záznamu ?

Scharioth Macula Lens: A new intraocular implant for low-vision patients with stabilized maculopathy- first experience

J. Nekolova, P. Rozsival, M. Sin, N. Jiraskova

. 2017 ; 161 (2) : 206-209. [pub] 20170426

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016110

AIMS: To present the initial results of Scharioth Macula Lens (SML) implantation. The SML is a new add-on intraocular lens designed to increase uncorrected near visual acuity (UCVA) in patients with stabilized maculopathy. METHODS: Eight patients were included in the study. All met the indication criteria before SML implantation. An SML was implanted in the better seeing eye. Near and distance visual acuity were tested. Possible complications and patient complaints were recorded and patients were asked about their quality of vision after SML implantation. The examination was carried out on day 1, 1 week, 1, 3 and 6 months after surgery. RESULTS: Six-month-results are presented. Apart from one, all patients with the SML had good near visual acuity at a recommended reading distance of 15 cm. Preoperatively, the mean (min-max) near UCVA was J13 (J8-J16), mean distance BCVA was 0.27. Postoperatively, the best results were after 1 month - near UCVA was J2.5 (J1-J7), distance BCVA was 0.26. Three months after surgery, this decreased to J4.5 (J1-J8); distance VA remained 0.25. Six months postoperatively - near vision was J4 (J1-J8) and distance VA was unchanged. Patients reported problems with reading speed and reading distance. Daily exercise improved their reading ability. One patient converted to wet AMD 3 months post-implantation. CONCLUSION: The SML is a new hope for low-vision patients. It acts as a magnifier in the eye. It is a suitable method for increasing near visual acuity in patients with inactive maculopathy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016110
003      
CZ-PrNML
005      
20180530111246.0
007      
ta
008      
180514s2017 xr a f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2017.014 $2 doi
035    __
$a (PubMed)28452378
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Nekolová, Jana $u Department of Ophthalmology, University Hospital in Hradec Kralove, Czech Republic $7 xx0237420
245    10
$a Scharioth Macula Lens: A new intraocular implant for low-vision patients with stabilized maculopathy- first experience / $c J. Nekolova, P. Rozsival, M. Sin, N. Jiraskova
520    9_
$a AIMS: To present the initial results of Scharioth Macula Lens (SML) implantation. The SML is a new add-on intraocular lens designed to increase uncorrected near visual acuity (UCVA) in patients with stabilized maculopathy. METHODS: Eight patients were included in the study. All met the indication criteria before SML implantation. An SML was implanted in the better seeing eye. Near and distance visual acuity were tested. Possible complications and patient complaints were recorded and patients were asked about their quality of vision after SML implantation. The examination was carried out on day 1, 1 week, 1, 3 and 6 months after surgery. RESULTS: Six-month-results are presented. Apart from one, all patients with the SML had good near visual acuity at a recommended reading distance of 15 cm. Preoperatively, the mean (min-max) near UCVA was J13 (J8-J16), mean distance BCVA was 0.27. Postoperatively, the best results were after 1 month - near UCVA was J2.5 (J1-J7), distance BCVA was 0.26. Three months after surgery, this decreased to J4.5 (J1-J8); distance VA remained 0.25. Six months postoperatively - near vision was J4 (J1-J8) and distance VA was unchanged. Patients reported problems with reading speed and reading distance. Daily exercise improved their reading ability. One patient converted to wet AMD 3 months post-implantation. CONCLUSION: The SML is a new hope for low-vision patients. It acts as a magnifier in the eye. It is a suitable method for increasing near visual acuity in patients with inactive maculopathy.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a implantace nitrooční čočky $x přístrojové vybavení $x metody $7 D019654
650    12
$a nitrooční čočky $7 D007910
650    _2
$a macula lutea $x patofyziologie $x chirurgie $7 D008266
650    _2
$a makulární degenerace $x chirurgie $7 D008268
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a zraková ostrost $x fyziologie $7 D014792
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rozsíval, Pavel, $u Department of Ophthalmology, University Hospital in Hradec Kralove, Czech Republic. $d 1950- $7 nlk19990073794
700    1_
$a Šín, Martin $u Department of Ophtalmology, University Hospital Olomouc, Czech Republic. $7 xx0095569
700    1_
$a Jirásková, Naďa, $u Department of Ophthalmology, University Hospital in Hradec Kralove, Czech Republic. $d 1965- $7 mzk2007395044
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 161, č. 2 (2017), s. 206-209
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28452378 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20180514 $b ABA008
991    __
$a 20180530111440 $b ABA008
999    __
$a ok $b bmc $g 1303306 $s 1012950
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 161 $c 2 $d 206-209 $e 20170426 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20180514

Najít záznam

Citační ukazatele

Možnosti archivace